NSE:SUNPHARMA Statistics
Total Valuation
NSE:SUNPHARMA has a market cap or net worth of INR 3.99 trillion. The enterprise value is 3.77 trillion.
Market Cap | 3.99T |
Enterprise Value | 3.77T |
Important Dates
The last earnings date was Thursday, May 22, 2025.
Earnings Date | May 22, 2025 |
Ex-Dividend Date | Jul 7, 2025 |
Share Statistics
NSE:SUNPHARMA has 2.40 billion shares outstanding. The number of shares has decreased by -0.11% in one year.
Current Share Class | 2.40B |
Shares Outstanding | 2.40B |
Shares Change (YoY) | -0.11% |
Shares Change (QoQ) | -0.45% |
Owned by Insiders (%) | 12.01% |
Owned by Institutions (%) | 28.50% |
Float | 1.04B |
Valuation Ratios
The trailing PE ratio is 36.51 and the forward PE ratio is 32.03. NSE:SUNPHARMA's PEG ratio is 2.26.
PE Ratio | 36.51 |
Forward PE | 32.03 |
PS Ratio | 7.60 |
PB Ratio | 5.51 |
P/TBV Ratio | 7.36 |
P/FCF Ratio | 33.45 |
P/OCF Ratio | 28.39 |
PEG Ratio | 2.26 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.02, with an EV/FCF ratio of 31.57.
EV / Earnings | 34.51 |
EV / Sales | 7.17 |
EV / EBITDA | 25.02 |
EV / EBIT | 30.18 |
EV / FCF | 31.57 |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.03.
Current Ratio | 2.89 |
Quick Ratio | 2.09 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.16 |
Debt / FCF | 0.20 |
Interest Coverage | 54.07 |
Financial Efficiency
Return on equity (ROE) is 15.71% and return on invested capital (ROIC) is 10.77%.
Return on Equity (ROE) | 15.71% |
Return on Assets (ROA) | 8.81% |
Return on Invested Capital (ROIC) | 10.77% |
Return on Capital Employed (ROCE) | 16.93% |
Revenue Per Employee | 12.23M |
Profits Per Employee | 2.54M |
Employee Count | 43,000 |
Asset Turnover | 0.59 |
Inventory Turnover | 1.05 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.52% in the last 52 weeks. The beta is 0.38, so NSE:SUNPHARMA's price volatility has been lower than the market average.
Beta (5Y) | 0.38 |
52-Week Price Change | +14.52% |
50-Day Moving Average | 1,734.52 |
200-Day Moving Average | 1,779.05 |
Relative Strength Index (RSI) | 40.14 |
Average Volume (20 Days) | 3,267,763 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SUNPHARMA had revenue of INR 525.78 billion and earned 109.29 billion in profits. Earnings per share was 45.60.
Revenue | 525.78B |
Gross Profit | 418.31B |
Operating Income | 125.11B |
Pretax Income | 137.37B |
Net Income | 109.29B |
EBITDA | 150.86B |
EBIT | 125.11B |
Earnings Per Share (EPS) | 45.60 |
Balance Sheet
The company has 249.88 billion in cash and 23.62 billion in debt, giving a net cash position of 226.26 billion or 94.30 per share.
Cash & Cash Equivalents | 249.88B |
Total Debt | 23.62B |
Net Cash | 226.26B |
Net Cash Per Share | 94.30 |
Equity (Book Value) | 724.86B |
Book Value Per Share | 302.32 |
Working Capital | 344.30B |
Cash Flow
In the last 12 months, operating cash flow was 140.72 billion and capital expenditures -21.29 billion, giving a free cash flow of 119.44 billion.
Operating Cash Flow | 140.72B |
Capital Expenditures | -21.29B |
Free Cash Flow | 119.44B |
FCF Per Share | 49.78 |
Margins
Gross margin is 79.56%, with operating and profit margins of 23.79% and 20.79%.
Gross Margin | 79.56% |
Operating Margin | 23.79% |
Pretax Margin | 26.13% |
Profit Margin | 20.79% |
EBITDA Margin | 28.69% |
EBIT Margin | 23.79% |
FCF Margin | 22.72% |
Dividends & Yields
This stock pays an annual dividend of 16.00, which amounts to a dividend yield of 0.96%.
Dividend Per Share | 16.00 |
Dividend Yield | 0.96% |
Dividend Growth (YoY) | 18.52% |
Years of Dividend Growth | 6 |
Payout Ratio | 33.07% |
Buyback Yield | 0.11% |
Shareholder Yield | 1.07% |
Earnings Yield | 2.74% |
FCF Yield | 2.99% |
Stock Splits
The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.
Last Split Date | Jul 29, 2013 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |